Researchers are looking for less aggressive cancer therapies that won't affect odds of survival. One new study shows HER2-positive breast cancer patients were successfully treated without chemotherapy.
from WebMD Health https://ift.tt/BNwrfjC
Researchers are looking for less aggressive cancer therapies that won't affect odds of survival. One new study shows HER2-positive breast cancer patients were successfully treated without chemotherapy.
A study says ribociclib, a drug approved for treating advanced-stage breast cancer, may help reduce the risk of recurrence in women who have been treated for certain types of early-stage breast cancer. Research is ongoing.
A study says ribociclib, a drug approved for treating advanced-stage breast cancer, may help reduce the risk of recurrence in women who have been treated for certain types of early-stage breast cancer. Research is ongoing.
As adults get older, they're often prescribed more and more medications to help manage various ailments. But often these people must also advocate for a hard look at what is no longer needed.